IBFCSM CPSO study materials
IBFCSM CPSO study resources

Cyclist with ADHD and a Contaminated Supplement

IBFCSM CPSO · Put your knowledge to work in context.

All case studies

Cyclist with ADHD and a Contaminated Supplement

A 27-year-old elite female cyclist is preparing for a UCI Gran Fondo in 5 weeks. She has ADHD and takes extended-release methylphenidate 36 mg each morning, prescribed by her psychiatrist for 3 years. She also uses a locally purchased pre-workout powder that lists a proprietary energy blend and is marketed as natural and drug-free. She has never applied for a therapeutic use exemption. She asks whether she can continue both products through the race and whether the supplement could cause a positive test. She reports no palpitations, but her resting heart rate is 58 bpm and blood pressure 118/72 mmHg. She is anxious about focus during the mass start and has considered taking an extra dose on race morning.

1. What is the anti-doping status of methylphenidate, and what should she do about a TUE?

Read the worked answer

Methylphenidate is a non-specified stimulant prohibited in competition under WADA class S6. It is permitted out of competition, but an in-competition TUE is required if she competes while taking it. She should not assume her prescription is sufficient. She needs to apply through her national anti-doping organization well before the event, with documentation of diagnosis, medical history, dose, and why alternative non-prohibited medications are inadequate. TUE criteria include that the athlete would experience significant impairment without the medication, that the treatment is not for a condition for which a prohibited substance is already available, and that there is no reasonable alternative. A retroactive TUE is generally not accepted for a known competition. If no TUE is granted, she must either stop the medication under psychiatric supervision or not compete; abrupt cessation is not advised. Check the current WADA Prohibited List and Global DRO for every product, and carry the TUE documentation.

2. How should you counsel her about the pre-workout supplement and contamination risk?

Read the worked answer

Supplement risk is real: natural and drug-free are marketing claims, not quality guarantees. Proprietary blends can contain undeclared stimulants or contaminants, and contamination can cause an adverse analytical finding. Under strict liability, she is responsible for what is in her body. Advice: stop the pre-workout now; do not use any supplement without checking every ingredient against the Prohibited List and using a batch-tested product from a reputable manufacturer; keep the label and batch number; and report any adverse effects. Food-first strategies and caffeine, if permitted and tolerated, can be discussed, but caffeine is monitored rather than prohibited. She should disclose all supplements to her physician and anti-doping organization. If she wants a focus aid, behavioral strategies and sleep hygiene are safer. No supplement is guaranteed safe, so the only zero-risk option is no supplement.

3. She plans to take an extra dose on race morning for focus. How do you respond professionally?

Read the worked answer

Taking an extra dose on race morning is not acceptable. It increases cardiovascular and psychiatric risk, including tachycardia, hypertension, anxiety, and insomnia, and it may exceed the dose covered by a TUE. The professional response is to refuse to endorse it, explain the anti-doping and medical risks, and refer her to her psychiatrist for dose optimization. Explore the anxiety: pre-race nerves are common, and cognitive strategies, breathing, routine, and realistic goal-setting may help. Document the discussion and her decision. If she insists on competing without a TUE or with an extra dose, counsel her that she may be disqualified and that you cannot support it. Maintain confidentiality; do not discuss her diagnosis with the coach. This is both an ethical and a safety issue.